Journal
VETERINARY PARASITOLOGY
Volume 244, Issue -, Pages 25-34Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.vetpar.2017.06.020
Keywords
Dermanyssus gallinae; Vaccine; Field trial; Serpin; Vitellogenin; Soluble mite extract (SME); Poultry red mite
Categories
Funding
- Scottish Government
- BBRSC [BB/J01513X/1]
- Zoetis
- Akita Co. Ltd.
- British Egg Marketing Board Trust
- Genomia
- BBSRC [BB/J01513X/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/J01513X/1] Funding Source: researchfish
Ask authors/readers for more resources
Vaccination is a desirable emerging strategy to combat poultry red mite (PRM), Dermanyssus gallinae. We performed trials, in laying hens in a commercial-style cage facility, to test the vaccine efficacy of a native preparation of soluble mite extract (SME) and of a recombinant antigen cocktail vaccine containing bacterially expressed versions of the immunogenic SME proteins Deg-SRP-1, Deg-VIT-1 and Deg-PUF-1. Hens (n = 384 per group) were injected with either vaccine or adjuvant only (control group) at 12 and 17 weeks of age and then challenged with PRM 10 days later. PRM counts were monitored and, at the termination of the challenge period (17 weeks post challenge), average PRM counts in cages containing birds vaccinated with SME were reduced by 78% (p < 0.001), compared with those in the adjuvant-only control group. When the trial was repeated using the recombinant antigen cocktail vaccine, no statistically significant differences in mean PRM numbers were observed in cages containing vaccinated or adjuvant-only immunised birds. The roles of antigen-specific antibody levels and duration in providing vaccine-induced and exposure-related protective immunity are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available